Drug Fact Sheet - DEA.gov
Marijuana Overview Marijuana is a mind-altering (psychoactive) drug, produced by the Cannabis sativa plant. Marijuana contains over 400 chemicals.
Download Drug Fact Sheet - DEA.gov
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Drug Fact Sheet
www.dea.govMarijuana Overview Marijuana is a mind-altering (psychoactive) drug, produced by the Cannabis sativa plant. Marijuana contains over 400 chemicals.
Frequently Asked Questions - dea.gov
www.dea.govClick the below link to access the “Application Manager Quick Start Guide”. The Application Manager Quick Start Guide contains information about how to use USAJOBS ... Note: USAJobs is accessible via firebird machines. Back to Top Who do I contact if I am having login issues with USAJOBS? To report login issues, contact the USAJOBS Customer ...
www.dea.gov
www.dea.govCommerce Section, operates the Controlled Substance Ordering System (CSOS) whose purpose is to issue and revoke digital signatures to DEA Registrants (manufactures, distributors, and pharmacies who order controlled substances) to digitally sign electronic orders for controlled
System, Ordering, Substance, Controlled, Controlled substances, Ordering system
Drug Slang Code Words - DEA.gov
www.dea.govDEA Intelligence Brief UNCLASSIFIED . Drug Slang Code Words . DEA Intelligence . DEA-HOU-DIR-020-17 . May 2017 . Report (U) This product was prepared by the DEA Houston Division.
Overcoming Procrastination - DEA
www.dea.govOvercoming Procrastination o Examine your reasons for procrastinating o Think about the task with the highest priority o Break long-term tasks into smaller bites o Visualize completing each task o Analyze your work habits o Schedule unpleasant tasks first o …
Drug Fact Sheet: Ectasty/MDMA - Home | DEA.gov
www.dea.govMDMA acts as both a stimulant and psychedelic, producing an energizing effect, distortions in time and perception, and enhanced enjoyment of tactile experiences. Adolescents and young adults use it to reduce inhibitions and to promote: • Euphoria, feelings of closeness, empathy, and sexuality Although MDMA is known among users as
The Drug Enforcement Administration (DEA) 1980-1985
www.dea.govFlorida and Georgia placed methaqualone in Schedule I, elimi nating its medical use in those states. At the peak of the U.S. methaqualone problem in the early 1980s, an estimated 85 percent of the methaqualone tablets that were being abused in the U.S. were counterfeit quaalude tablets from overseas sources. In response, the DEA Diversion Control
UNCLASSIFIED - Home | DEA.gov
www.dea.govof drug overdose deaths is almost certainly much higher than the numbers officially reported. The 2018 National Drug Threat Assessment (NDTA)1 is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug …
This page intentionally left blank. - Home | DEA.gov
www.dea.govJan 14, 2020 · 2019 National Drug Threat Assessment (NDTA) a. is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of both licit and illicit drugs. The report combines federal, state, local, and tribal law enforcement
Assessment, Threats, Drug, National, Trafficking, National drug threat assessment, Drug trafficking
Drug Fact Sheet: Amphetamines - DEA
www.dea.govto treat attention-deficit hyperactivity disorder (ADHD). WHAT IS THEIR ORIGIN? Amphetamines were first marketed in the 1930s as Benzedrine in an over-the-counter inhaler to treat nasal congestion. By 1937 amphetamines were available by prescription in tablet form and were used in the treatment of the sleeping disorder narcolepsy and ADHD.
Fact, Sheet, Fact sheet, Attention, Deficit, Hyperactivity, Deficit hyperactivity
Related documents
DSM-5: What Counselors Need to Know
www.lacounseling.orgIntroduction •Why change the DSM? •The purpose of a diagnosis –Common language –Inform clinical care •Overview of today’s workshop
LUNDBECK
www.lundbeck.comlundbeck - un global compact 2017 communication on progress report 1 lundbeck un global compact 2017 communication on progress report
Benefit summary 2018 - Pty Ltd
www.verimedptyltd.co.zaMedicine Note: • Benefits below may be subject to pre-authorisation, clinical protocols, pre-ferred providers, designated service providers (DSPs), formularies, funding
Information sheet Premature death among people …
www.who.intInformation sheet . Premature death among people with severe mental disorders. 1. Key facts • People with severe mental disorders on average tend to …
Information, With, People, Death, Premature, Among, Premature death among people, Premature death among people with
FOR PROBATION WORKERS’ - …
memberfiles.freewebs.commental health awareness trainers guide 3 probation service west midlands regional development centre introduction how the training pack can be used
ZYPREXA RELPREVV Patient Care Program …
www.zyprexarelprevvprogram.comPlease see Prescribing Information for full details about the risks of ZYPREXA RELPREVV, including Boxed Warnings. ZYPREXA RELPREVV Patient Care Program Instructions Brochure
Programs, Information, Patients, Instructions, Care, Brochure, Relprevv patient care program, Relprevv, Relprevv patient care program instructions brochure